Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01352000 · ClinicalTrials.gov registry record · NA
Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 3,830
- Enrollment target
NCT01352000: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT01352000 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 3,830 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (173% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01352000, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,830 participants
- Enrollment target
Study Summary
The study primary purpose is smoking relapse prevention. This study is a collaboration between researchers who developed the relapse-prevention intervention, at the H. Lee Moffitt Cancer Center in Tampa, Florida, and those associated with the "New York State Smokers' Quitline" (NYSSQL), at Roswell Park Cancer Institute in Buffalo, New York.
Primary Outcome
To test the effectiveness of a self-help, relapse-prevention intervention (Forever Free booklets) as an adjunct to a state telephone quitline
Interventions
- BEHAVIORAL Smoking Cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,830 participants |
| Start Date | 2008-12 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT01352000 record still lists
NCT01352000 is an interventional study that assigns participants to a tested intervention. Its 3,830 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (173% higher).
The record links to 0 conditions, and to 1 intervention - of which Smoking Cessation is the first listed.
NCT01352000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01352000 about?
NCT01352000 is a clinical study titled "Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")". The study primary purpose is smoking relapse prevention. This study is a collaboration between researchers who developed the relapse-prevention intervention, at the H. Lee Moffitt Cancer Center in Tampa, Florida, and those associated with the "New York State Smokers' Quitline" (NYSSQL), at Roswell P...
What is the current status of trial NCT01352000?
This trial is currently completed. It is a NA study. The enrollment target is 3,830 participants. The study started on 2008-12. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01352000?
The interventions under investigation include: Smoking Cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01352000?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01352000's enrollment target sits among peer trials
3,830 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia